In vitro activities of the new ketolide antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae in Germany

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 6, 1998, Pages 1509-1511

  Reinert, Ralf René ^a   Bryskier, André ^b   Lütticken, Rudolf ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CLARITHROMYCIN; ERYTHROMYCIN; HMR 3004; JOSAMYCIN; KETOLIDE; MACROLIDE; OFLOXACIN; PENICILLIN G; ROXITHROMYCIN; TELITHROMYCIN; TETRACYCLINE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; CROSS RESISTANCE; DILUTION; DRUG ACTIVITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIA;

EID: 0031805506     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.6.1509     Document Type: Article

References (22)

1. Appelbaum, P. C. 1992. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin. Infect. Dis. 15:77-83.
2. Barry, A. L., S. D. Brown, and P. C. Fuchs. 1947. Antipneumococcal activity of a ketolide (HMR 3647) and seven related drugs in vitro, abstr. F-107, p. 164. In Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
3. Barry, A., P. Fuchs, and S. Brown. 1997. In vitro activity of the new ketolide HMR 3004 compared to an azalide and macrolides against Streptococcus pneumoniae and Haemophilus influenzae. Eur. J. Clin. Microbiol. Infect. Dis. 16:767-769.
4. Doern, G., A. Brueggemann, H. P. Holley, and A. M. Rauch. 1996. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicroh. Agents Chemother. 40: 1208-1213.
5. Ednie, L. M., S. K. Spangler, M. R. Jacobs, and P. C. Appelbaum. 1997. Susceptibilities of 228 penicillin- and erythromycin-susceptible and -resistant pneumococci to RU 64004, a new ketolide, compared with susceptibilities to 16 other agents. Antimicrob. Agents Chemother. 41:1033-1036.
6. Fenoll, A., C. Martin-Bourgon, R. Munoz, D. Vicioso, and J. Casal. 1991. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979-1989. Rev. Infect. Dis. 13:56-60.
7. Geslin, P., A. Buu-Hoi, A. Fremaux, and J. F. Acar. 1992. Antimicrobial resistance in Streptococcus pneumoniae: an epidemiological survey in France, 1970-1990. Clin. Infect. Dis. 15:95-98.
8. Jamjian, C., D. J. Biedenbach, and R. N. Jones. 1997. In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004. Antimicrob. Agents Chemother. 41:454-459.
9. Jones, R., and D. Biedenbach. 1997. Antimicrobial activity of RU-66647, a new ketolide. Diagn. Microbiol. Infect. Dis. 27:7-12.
10. Kaufhold, A., R. Lütticken, and J. Henrichsen. 1987. Capsular types and antibiotic susceptibility of Streptococcus pneumoniae isolated from patients with systemic infections in West Germany. Eur. J. Clin. Microbiol. 6:696-697.
11. Klugman, K., F. Goldstein, S. Kohno, and F. Baquero. 1997. The role of fourth-generation cephalosporins in the treatment of infections caused by penicillin-resistant streptococci. Clin. Microbiol. Infect. 3(Suppl. 1):S48-S60.
12. Klugman, K. P. 1990. Pneumococcal resistance to antibiotics. Clin. Microbiol. Rev. 3:171-196.
13. Marton, A. 1992. Pneumococcal antimicrobial resistance: the problem in Hungary. Clin. Infect. Dis. 15:106-111.
14. Milatovic, D., K. Machka, W. Heck, and I. Braveny. 1981. Serotypes and antimicrobial susceptibility of Streptococcus pneumoniae in West Germany. Infection 9:220-222.
15. National Committee for Clinical Laboratory Standards. 1998. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. Approved standard M100-S8. National Committee for Clinical Laboratory Standards document M7-A4. National Committee for Clinical Laboratory Standards, Villanova, Pa.
16. Pankuch, G. A., M. R. Jacobs, and P. C. Appelbaum. 1997. Antipneumococcal activity (MIC) of RU 66647, a new ketolide, compared to 16 other agents, abstr. F-108, p. 164. In Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
17. Reinert, R. R. 1997. Antibiotic resistance in Streptococcus pneumoniae. Biospekrum. 1997(Special issue):27-30.
18. Reinert, R. R., A. Kaufhold, J. J. Schläger, V. Mechery, and R. Lütticken. 1997. Serotype distribution and antibiotic susceptibility of Streptococcus pneumoniae isolates causing systemic infections among children in Germany, 1992 to 1996. Pediatr. Infect. Dis. J. 16:244-245.
19. Reinert, R. R., A. Kaufhold, and H. Kierdorf. 1992. Penicillin-resistant pneumococcus in community-acquired bacteremic pneumonia in Germany. Infection 20:238-239.
20. Reinert, R. R., R. Lütticken, and A. Kaufhold. 1993. Aktuelle Daten zur Antibiotikaempfindlichkeit von Streptococcus pneumoniae (Pneumokokken). Die Bedeutung von penicillinresistenten Isolaten. Med. Klin. 88:357-361.
21. Reinert, R. R., A. Queck, A. Kaufhold, M. Kresken, and R. Lütticken. 1995. Antimicrobial resistance and type distribution of Streptococcus pneumoniae in Germany, 1992-1994. Clin. Infect. Dis. 21:1398-1401.
22. Schülin, T., C. Wennersten, R. Moellering, Jr., and G. Eliopoulos. 1997. In vitro activity of RU 64004, a ketolide antibiotic, against gram-positive bacteria. Antimicrob. Agents Chemother. 41:1196-1202.